Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Sick Sinus Syndrome

ClinicalTrials.gov lists 91 trials for Sick Sinus Syndrome or a narrower condition beneath it. Abbott Medical Devices has the most among industry and government lead sponsors, with 11.

MeSH D012804 Cardiovascular Diseases C14 C23
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 2/3 Phase 2/3 2 Phase 3 Phase 3 3 Phase 4 Phase 4 11 Not applicable Not applicable 46 Observational Observational 29 Phase 2/3 Phase 2/3 2 Phase 3 Phase 3 3 Phase 4 Phase 4 11 Not applicable Not applicable 46 Observational Observational 29

Trials per phase (log scale)

91 of the 91 trials are tagged with Sick Sinus Syndrome itself; the rest are tagged with a narrower condition beneath it.

Get the Sick Sinus Syndrome report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Sick Sinus Syndrome trials start? (26)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 6

1995: 1 trials (Phase 3 1) 1999: 1 trials (Phase 2/3 1) 2000: 2 trials (Observational 1, Phase 4 1) 2003: 5 trials (Not applicable 2, Phase 4 3) 2004: 4 trials (Phase 4 4) 2005: 2 trials (Observational 1, Not applicable 1) 2006: 3 trials (Observational 2, Phase 4 1) 2007: 3 trials (Observational 1, Not applicable 1, Phase 4 1) 2008: 2 trials (Observational 1, Not applicable 1) 2009: 3 trials (Observational 2, Not applicable 1) 2010: 3 trials (Not applicable 3) 2011: 6 trials (Observational 3, Not applicable 3) 2012: 5 trials (Observational 3, Not applicable 2) 2013: 5 trials (Not applicable 5) 2014: 5 trials (Observational 2, Not applicable 2, Phase 3 1) 2015: 3 trials (Not applicable 2, Phase 4 1) 2016: 2 trials (Not applicable 1, Phase 3 1) 2018: 4 trials (Observational 3, Not applicable 1) 2019: 3 trials (Not applicable 3) 2020: 3 trials (Not applicable 3) 2021: 3 trials (Not applicable 2, Phase 2/3 1) 2022: 5 trials (Observational 1, Not applicable 4) 2023: 4 trials (Observational 3, Not applicable 1) 2024: 4 trials (Not applicable 4) 2025: 6 trials (Observational 4, Not applicable 2)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 4
2025 6
2024 4
2023 4
2022 5
2021 3
2020 3
2019 3
2018 4
2016 2

No forecast is made for this condition: it averages 4.4 trial starts a year over the five years to September, under the 5 a year the method needs.

Prediction, not a registry value: median of 36 months from start to primary completion across 7 trials still running at the 2026-10-09 snapshot; registered median of 32 months across 48 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Sick Sinus Syndrome trials in? (5)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 2/3 2
Phase 3 3
Phase 4 11
Not applicable 46
Observational 29

How many Sick Sinus Syndrome trials are recruiting? (7)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 5
Recruiting 10
Enrolling by invitation 1
Completed 46
Terminated 9

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Sick Sinus Syndrome trials? (9)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
Abbott Medical Devices 11
Medtronic Cardiac Rhythm and Heart Failure 7
Boston Scientific Corporation 5
Biotronik SE & Co. KG 4
Medtronic BRC 4

Which drugs are being tested for Sick Sinus Syndrome? (3)

Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.

Drugs tested
Drug Trials
NEBIVOLOL 1
Ivabradine 1
Atenolol 1

Interventions as named in the registry (10)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
Low dose losartan 1
Routine Management 1
polymixin/bacitracin 1
Focal Cryoablation 1
Pacemaker and defibrillator 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which serious adverse events do Sick Sinus Syndrome trials report? (10)

Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.

Serious adverse events in this condition's trials
Adverse event Subjects affected Trials
Non-cardiovascular 357 1
Cardiovascular - Non-Heart Failure 241 1
Cardiovascular - Heart Failure 101 1
Other 49 1
Cardiac Arrhythmia - Atrial Fibrillation 41 1

Which publications cover Sick Sinus Syndrome? (91)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Prevalence (4)

Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.

Prevalence
Orphanet disease Type Class Geography Jurisdiction Mapping relation
Hereditary sick sinus syndrome Cases families Worldwide Not stated Exact
Hereditary sick sinus syndrome Point prevalence <1 / 1 000 000 Worldwide Not stated Exact
Hereditary sick sinus syndrome Point prevalence <1 / 1 000 000 Worldwide Not stated Exact
Hereditary sick sinus syndrome Cases families Worldwide Not stated Exact

Rare-disease identity (2)

Shown in this order: exact, broader, narrower, other.

Rare-disease identity
Orphanet disease ORPHA code Relation Source
Hereditary sick sinus syndrome 166282 Exact Orphanet Rare Disease Ontology (ORDO)
Hereditary sick sinus syndrome 166282 Exact Orphadata Science knowledge files, Product 1

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: sub-conditions in mesh.

Browse all condition evidence pages